Liver enzymes and the muscle you mistook for a liver

Most raised liver enzymes on cycle are not the liver Strong evidence

AST and ALT are called liver enzymes, which is where the trouble starts. ALT is reasonably liver-specific. AST is not: it is abundant in skeletal muscle, cardiac muscle and red cells, so anything that damages muscle puts it into the blood. Resistance training damages muscle on purpose.

The cleanest demonstration of what that does to a blood panel is a 2008 study in the British Journal of Clinical Pharmacology with a title that gives away the finding: muscular exercise can cause highly pathological liver function tests in healthy men. Pettersson and colleagues took 15 healthy men with no weightlifting history, put them through a single one-hour resistance session, then tracked their bloods. AST and ALT rose in every participant, alongside lactate dehydrogenase, creatine kinase and myoglobin. The elevations were not brief. They were still significant seven days later.

Sit with that for a moment. Fifteen untrained men, one gym session, no drugs of any kind, then a week of liver function tests that a doctor reading them cold would call pathological. Now add a person who trains four times a week, runs an oral and took a set of bloods the morning after legs. Three explanations are available for their raised ALT. Only one of them is the drug.

The four numbers that tell you which it is Strong evidence

You cannot separate muscle from liver with AST and ALT alone. You can separate them almost every time by adding two more.

GGT is the discriminator. It lives in the liver and biliary tract, not in skeletal muscle, so exercise does not move it. Raised AST and ALT with a normal GGT points hard at muscle. Raised AST and ALT with a raised GGT points at the liver or the bile ducts. One caveat that matters in this population: GGT is also raised by alcohol, so it answers "is this hepatic" rather than "is this the compound".

CK is the confirmation. Creatine kinase is essentially muscle-specific, so a high CK moving in step with AST tells you where the AST came from. The pattern is coherent rather than coincidental.

Bilirubin is the one people skip and the one that changes the decision. Transaminases tell you cells are leaking. Bilirubin tells you the liver is failing to do its job, which is a different and more serious statement. The classic anabolic steroid injury is cholestatic, meaning bile flow is impaired. In that pattern bilirubin and alkaline phosphatase move while ALT may be unremarkable. Someone watching only ALT can watch the wrong number for months.

What is actually hepatotoxic and what is not Strong evidence

The distinction is structural rather than a matter of degree. A 17-alpha-alkyl group is added to make a steroid survive first-pass metabolism so it can be swallowed. That is exactly why it is orally active. It is also why it strains the liver: the modification that stops the liver clearing the molecule quickly is the modification that keeps the molecule in front of the liver. The 2022 review in the World Journal of Gastroenterology puts it plainly, that 17-alpha-alkylated compounds appear to be hepatotoxic while non-alkylated ones appear not to be.

That maps to a practical split. The oral alkylated compounds carry this risk as a class property. Injectable esters of testosterone, nandrolone, trenbolone, boldenone or drostanolone are not alkylated, are not delivered through the portal circulation and do not carry the same hepatic signal. The cycle calculator flags which compounds in a stack are alkylated, because it is a fact about the molecule rather than a guess about you.

The same review describes four distinct forms of injury, which is worth knowing because they are not one thing on a spectrum. A transient rise in enzymes. Acute cholestatic injury. Chronic vascular injury, including peliosis hepatis, where blood-filled cavities form in the liver. And hepatic tumors, both benign adenomas and hepatocellular carcinoma. The first is common and usually reversible. The last three are rare, serious and mostly reported with prolonged high-dose alkylated oral use.

How to take bloods that mean something Mixed

Given Pettersson, the single highest-value change most people can make costs nothing: do not train hard in the week before the draw. Not the day before, not three days before. Their markers were still elevated at seven days. If a full week is impractical, take the longest gap you can and record what training happened, so a rise can at least be read against it.

The rest follows from the table above. Order GGT and CK alongside AST and ALT, or the result is uninterpretable. Include bilirubin and ALP if anything alkylated is involved. Draw at the same point in the week each time so a trend is a trend. And take a baseline before starting anything, because a single number without a personal reference range is close to useless: plenty of people who lift sit above the population range at rest. The bloodwork guide covers the full panel and the timing rules. Hematocrit is the other marker on it that people act on with the least evidence.

The supplement layer Emerging

TUDCA and NAC are the two most commonly recommended liver supports on cycle. They are not equivalent in evidence.

NAC has a real clinical pedigree, as the antidote in paracetamol overdose, where it works by replenishing glutathione in a specific toxic mechanism. Extending that to protection against alkylated steroid cholestasis is an extrapolation across mechanisms rather than a demonstrated effect.

TUDCA is a bile acid with genuine use in cholestatic liver disease, which at least makes it mechanistically aimed at the right injury pattern. What does not exist is a trial showing it prevents or reverses anabolic steroid hepatotoxicity in people using these compounds. Both are cheap and both are reasonably safe. Neither is evidence that a compound has been made safe. Treating them as a license to extend an oral is the way this belief does harm.